Experience

ACELYRIN Announces Pricing of Upsized Initial Public Offering

May 15, 2023

Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.

Read more

Related contacts

Chadwick Mills
Partner, San Francisco
Charlie Kim
Partner, San Diego
Anitha Anne
Associate, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Alexander Lee
Partner, Los Angeles Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Brad Goldberg
Partner, New York
Peter Adams
Partner, San Diego
Lauren Creel
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Patrick Gibbs
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Barbara Borden
Partner, San Diego
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Darren DeStefano
Partner, Reston
Francis Wheeler
Partner, Colorado
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Brett White
Of Counsel, Palo Alto
Dani Nazemian
Special Counsel, San Diego
Jennifer Shanley
Special Counsel, New York
Jacquelyn Burke
Special Counsel, Boston
Karen Tsai
Special Counsel, Washington DC
Miriam Petrillo
Special Counsel, Chicago
Andrew Nelms
Associate, San Francisco
Amy Mao
Associate, San Francisco
David D. Kim
Associate, San Francisco
Lawrence Traylor
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Nathaniel Hearn Jr.
Associate, New York
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Leman
Associate, Los Angeles Downtown
Kelly McCormick
Associate, San Francisco
Mor Agam
Associate, New York
Allison Kutner
Associate, New York
Madison (JJ) Meng
Associate, San Francisco
Rebecca Siegel
Associate, San Francisco
Rachel F. Katz
Associate, New York
Mari Dugas
Associate, Washington DC
Loriane Sangaré-Vayssac
Associate, Brussels
Megan Drill
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Kristin R. Marshall
Associate, Washington DC
John T. Stellini
Associate, Palo Alto
Luke X. Blackett
Associate, San Francisco

SCYNEXIS Announces Exclusive License Agreement With GSK for Brexafemme

April 4, 2023

Cooley advised SCYNEXIS on its exclusive license agreement with GSK for Brexafemme.

Related contacts

Marya Postner
Partner, Palo Alto
Carly Robinson
Associate, Reston
Bin Wang
Special Counsel, Palo Alto
Jonathan Kaufman
Associate, Palo Alto
Barbara Borden
Partner, San Diego
Rebecca Givner-Forbes
Special Counsel , Washington DC
Matthew Hemington
Partner, Palo Alto
Brett White
Of Counsel, Palo Alto
David Burns
Special Counsel, Washington DC
Nicollette R. Kirby
Associate, Washington DC
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Michael Egan
Partner, Washington DC
Andrea Batalla Eguidazu
Associate, London
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Natasha Leskovsek
Of Counsel, Washington DC
Elizabeth Anne Wright
Partner, Brussels

Structure Therapeutics – $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner, Singapore
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Alexander Lee
Partner, Los Angeles Santa Monica
Karen Deschaine
Partner, San Diego
Jie Zhang
Partner, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Partner, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington DC
Lisa Yuan
Special Counsel, Beijing
Jennifer Shanley
Special Counsel, New York
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Yuan Dai
Associate, Shanghai
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Alexander Davis
Associate, San Diego
Brian Lau
International Legal Project Manager, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Diego

CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion

January 10, 2023

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.

Read more

Related contacts

Rowook Park
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Special Counsel, New York
Benjamin “Izzy” Lubarsky
Associate, New York
Alessandra Murata
Partner, Palo Alto
Ajay Athavale
Associate, San Francisco
Megan Drill
Associate, San Diego
Melissa Meza
Associate, San Diego
Trey Reilly
Associate, New York
Amy Hallman Rice
Special Counsel, San Diego
Matthew D. Silverman
Special Counsel, San Diego
Howard Morse
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Charity Williams
Partner, San Diego
MaryBeth Shreiner
Associate, Reston
Elizabeth Lewis
Senior Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Patrick Sharma
Associate, Los Angeles Santa Monica
Karen Tsai
Special Counsel, Washington DC
Heidi A. Erlacher
Partner in Charge – Boston, Boston
Kristopher Kleiner
Special Counsel, Colorado
Ryan Sansom
Partner, Boston
Stephanie Gentile
Partner, New York
Aric Wu
Partner, New York
Christopher Kimball
Partner, Washington DC
Nyron J. Persaud
Partner, New York
Helenanne Connolly
Partner, Reston
Stella Sarma
Special Counsel, Brussels
Stella Sarma
Special Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Dillon Martinson
Special Counsel, Washington DC
Lindsey O'Crump
Associate, Washington DC
Vivian Tsai
Associate, Los Angeles Santa Monica
Arman Sagart
Associate, San Diego
Daniel Gillon
Associate, San Diego
Barry Kuang
Associate, Boston
Rajdeep Roger Bains
Associate, San Diego
Alexander Fullman
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Grace Hunter
Associate, Washington DC
Kindall G. Jackson
Associate, Washington DC
Dr. Xixi Sun
Associate, Boston
Sarah Curry
Associate, New York
Carly Mitchell
Associate, Washington DC
Jennifer Shanley
Special Counsel, New York
Wyatt Kernell
Associate, New York
Allison Kutner
Associate, New York

Tmunity Therapeutics Agrees to Sell to Kite

December 28, 2022

Cooley advised Tmunity Therapeutics, a clinical-stage biotechnology company, on its agreement to sell to Kite, a global biopharmaceutical company. Partners Mark Weeks, Ben Beerle and Marya Postner led the Cooley team.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Marya Postner
Partner, Palo Alto
Chen Chen
Associate, Palo Alto
Jenny Ge
Associate, San Francisco
Megan Browdie
Partner, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Todd Gluth
Partner, San Diego
Kate Hillier
Partner, Seattle
Phil Mitchell
Partner, New York
Howard Morse
Partner, Washington DC
David Walsh
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington DC
Stella Sarma
Special Counsel, Brussels
Andrew Bae
Associate, Washington DC
Baasit Bhutta
Associate, Palo Alto
Paula Fleckenstein
Associate, Reston
John Forrest
Associate, Boston
Joyce Li
Associate, Chicago
Lindsey O'Crump
Associate, Washington DC
Maya Rahwanji
Associate, New York
Patrick Sharma
Associate, Los Angeles Santa Monica
Rubin Waranch
Associate, Washington DC
Zimu Yang
Associate, Washington DC
Freddy Yip
Associate, Hong Kong
View more

Memberships & affiliations

American Bar Association

American Health Lawyers Association